Technology.

Skyline is a pioneering company with a tangible vision on translating discoveries from the laboratory directly to the daily practice of diagnostics. This process starts with synergistic collaborations with outstanding scientists. Step by step we prepare their discoveries for the market through further analysis and clinical validation. Our innovative products fulfill the promise of personalized medicine by providing tools to classify disease on a molecular basis.

  • Personalized Medicine in Cancer

    Molecular Biology and Genetics have provided the scientific and medical community with the understanding of cancer as a disease of our genes. While cancer in general refers to the occurrence of uncontrolled growth and spread of cells, it has become evident that this abnormal cellular behavior resulted from changes in...

    Read more >>

  • Microarray Technology

    Introduced commercially in 1994, microarray technology was first used as a research technology in the field of Genomics. Today, it is transforming health care as a powerful, new tool for diagnostic and prognostic applications. Chromosomal translocations, gene mutations and gene expression levels are pivotal information for cancer status and can...

    Read more >>

  • Publications

    Please follow these links for background publications about our product pipeline. Below you can find links to general background papers about personalized medicine and microarray technology.

    Read more >>
 

Dr. Molewaterplein 50, Suite Ee1971, 3015 GE Rotterdam. The Netherlands, Europe. Phone: +31 (0)10 7038410. Fax: +31 (0)10 7043076. E-mail: info@skyline-diagnostics.com